Thromboelastographic Modifications Induced by Intravenous and Subcutaneous Heparin Administration

• References

• 1 De Nicola P. Thromboelastography. Charles C Thomas; Springfield IL: 1957: 110
• 2 Eliot RS, von Kaulla KN, Blount G. Thromboelastographic studies with a twenty-four-hour schedule for subcutaneous heparin. Circulation 24: 1206-1214 1961;
• 3 Audier M, Serradimigni A. Savoir interpreter un thrombo-elastogramme au l’exploration precise de la coagulation sanguine. Maloine; Paris: 135 1962
• 4 Raby C. Hemorragias y trombosis. In: Exploración del tiempo trombodinámico. Toray-Masson; Barcelona: 1968: 190-211
• 5 Lee BY, Trainor FS, Kavner D, McCann WJ. Monitoring of heparin therapy with thromboelastography. Surg Gynecol Obstet 149: 843-846 1979;
• 6 Caprini JA, Vagher JP, Rabidi SJ, Mitchell JE. Laboratory monitoring of continuous intravenous heparin therapy. Thromb Res 29: 91-94 1983;
• 7 Spiess BD, Tuman KJ, McCarthy RJ, Delaria GA, Schilo R, Ivancovich AD. Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 3: 25-30 1987;
• 8 Tuman KJ, Spiess BD, Schoen RE, Ivankovich AD. Use of thromboelastography in the management of von Willebrand's disease during cardiopulmonary bypass. J Cardiothorac Anesth 1: 321-324 1987;
• 9 Gillies BSA, Spiess BD. Cardiopulmonary bypass coagulation management, education, and transfusion practice at the University of Washington. Am Society of Anesthesiology. October 1991 (Abst)
• 10 Soloway HB, Cox SP. In vitro comparison of the thrombin time and activated partial thromboplastin time in the laboratory control of heparin therapy. Am J Clin Pathol 60: 648-650 1973;
• 11 Bird R, Hall B, Hobbs KEF, Chapman D. : New haemocompatible polymers assessed by thromboelastography. J Biomed Eng 11: 231-234 1989;
• 12 Caprini JA, Eckenhoff JB, Ramstack JM, Zuckerman L, Mockros LF. Contact activation of heparinized plasma. Thromb Res 5: 379-400 1974;
• 13 Lee BY, Thoden WR, Del Guercio LRM et al Monitoring coagulation dynamics with thromboelastography. Contemp Surg 24: 19-24 1984;
• 14 Coppola L, Giunta R, Spiezia R, Nappo V, Scognamiglio C, Tirelli A. Accentuata ed irregolare detlessione postmassimale nei tracciati tromboelastografici: Incidenza in varie patologie. Boll Soc It Biol Sper 61: 263-270 1985;
• 15 Jespersen J. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Danish Med Bull 35: 1-33 1988;
• 16 De Gaetano G, Vermylen J. Effect of aspirin on the thrombelastogram of human blood. Thromb Diath Haemorrh 30: 494-498 1973;
• 17 Tuman KJ, McCarthy RJ, Patel RV, Patel RB, Ivankovich AD. Comparison of thromboelastography and platelet aggregometry. (Abst.) Anesthesiology 75: A433 1991;
• 18 Laster J. The heparin induced thrombocytopenic syndrome: An update. Surgery 102: 763-770 1987;
• 19 Copeland JG, Harker LA, Joist JH, De Vries WC. Circulatory support 1988. Bleeding and anticoagulation. Ann Thorac Surg 47: 87-95 1989;
• 20 Zuckerman L, Ramstack JM, Vagher JP, Caprini JA, Mockros LF. Neutralization of heparin by cellular blood elements. Thromb Res 7: 149-159 1975;
• 21 Ramstack JM, Zuckerman L, Mockros LF, Caprini JA, Vagher JP. Effect on platelet count and hematocrit on the coagulability of heparinized blood. Res Commun Chem Pathol Pharmacol 21: 327-341 1978;
• 22 Howland WS, Castro B, Fortner J, Gould P. Hypercoagulability, thrombelastographic monitoring during extensive hepatic surgery. Arch Surg 108: 605-608 1974;
• 23 Vagher JP, Caprini JA, Zuckerman L. Multi-system analysis of intravenous calcium and sodium heparin. Thromb Res 14: 881-900 1979;
• 24 De Takats G. Heparin tolerance. A test of the clotting mechanism. Surg Gynecol Obstet 77: 31-39 1943;
• 25 Traverso CI. Valoración del test de tolerancia a la heparina intravenosa realizado con tromboelastografia en la predicción de la enfermedad tromboembó1ica venosa tras cirugía general electiva. Granada University School of Medicine. Spain: doctoral thesis 1989
• 26 Lee BY, Trainor FS, Thoden WR, Kavner D. Handbook of Noninvasive Diagnostic Techniques in Vascular Surgery. Monitoring coagulation dynamics: Thromboelastography. In: Appleton-Century-Crofts; New York: 1981: 266-286
• 27 Bull HS, Huse WN, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 69: 685-689 1975;
• 28 Friesen RH, Clement AJ. Individual responses to heparinization for extracorporeal circulation. J Thorac Cardiovasc Surg 72: 875-879 1976;
• 29 Whitfield L, Schentag J, Levy G. Relationship between concentration and anticoagulant effect of heparin in plasma of hospitalized patients: magnitude and predictability of interindividual differences. Clin Pharmacol Ther 32: 503-516 1982;
• 30 Mockros LF, Hirsch SD, Zuckerman L, Caprini JA, Robinson WP, Vagher JP. Anticoagulation kinetics following bolus injection of heparin. Thromb Haemostas 42: 1248-1260 1979;
• 31 Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 95: 37s-51s 1989;
• 32 Walker A, Jick H. Predictors of bleeding during heparin therapy. JAMA 244: 1209-1212 1980;
• 33 Lee B, Taha S, Trainor F, Kavner D, McCann M. Monitoring heparin therapy with thromboelastography and activated partial thromboplastin time. World J Surg 4: 232-239 1980;
• 34 Raby C. Coagulaciones intravasculares diseminadas y localizadas. Toray-Masson; Barcelona: 1976: 255
• 35 Traverso CI. Estudio de las modificaciones tromboelastognificas inducidas por la heparina a bajas dosis y el dextrano 70 como profilaxis de la enfermedad tromboembó1ica venosa postoperatoria. Granada University School of Medicine. Spain: medical degree thesis, 1986
• 36 Aznar J, Soto F, Villa P, Lonjedo L, Bulufer P. Valoración tromboelastográfica de la hipercoagulabilidad plasmática. Sangre 24: 1-8 1979;
• 37 Torras-Barba J, Duran J, Pales A, Alloza J, Monasterio J, Triginer A. Valoración tromboelastográfica de la hipercoagulabilidad en pacientes traumatológicos sometidos a profilaxis con heparina cálcica. Sangre 25: 35-44 1980;
• 38 Arcelus JI, Traverso CI, López-Cantarero M et al. Estudio de las modificaciones tromboelastográficas inducidas por la heparinizción profiláctica en cirugía general. Cir Esp 43: 518-526 1988;
• 39 Butler MJ. Thromboelastography during and after elective abdominal surgery. Thromb Haemostas 39: 488-495 1978;
• 40 Fano R, Gonzalez H. Valor de la tromboelastografia en la detección de la hipercoagulabilidad plasmatica. Barcelona Quir 26: 288-294 1983;
• 41 Sagar S, Massey J, Sanderson JM. Low-dose heparin prophylaxis against fatal pulmonary embolism. Br M ed J 4: 257-261 1975;
• 42 Raby C, Couinaud C. Les trubles de la coagulation dans les hemorragies des hypertensions portales. Chirugie 102: 186-196 1976;
• 43 Duraffourd P. Les conditions de la fiabilite et les avantages du thromboelastogramme. Coeur 12: 447-455 1981;
• 44 Vemese NA, Spillert CR, Franco CD, Lazaro EJ. Thromboelastographic evaluation of mini-dose heparin in minor surgical procedures. Am Surg 2: 112-113 1986;
• 45 Kakkar VV, Corrigan TA, Fossard DP. Prevention of fatal postoperative pulmonary embolism by low doses of heparin Reappraisal of results. Intemational multicenter trial. Lancet 1: 567-571 1977;
• 46 Leyvraz PF, Richard J, Bachmann F, VanMelle G, Treyvaud J-M, Livio J-J, Candardjis G. Adjusted versus fixed-dose heparin in the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med 309: 954-958 1983;
• 47 Tabemer DA, Poller L, Thomson JM, Lemon G, Weighill FJ. Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery. Br J Surg 76: 933-935 1989;